Metabolomic rewiring promotes endocrine therapy resistance in breast cancer. Ahn S, Park JH, Grimm SL, Piyarathna DWB, et al. Cancer Res 2023 Oct 31. doi: 10.1158/0008-5472.CAN-23-0184.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ahn S, Park JH, Grimm SL, Piyarathna DWB, et al. Metabolomic rewiring promotes endocrine therapy resistance in breast cancer. Cancer Res 2023 Oct 31. doi: 10.1158/0008-5472.CAN-23-0184.
PMID: 37906431